Nystatin and Infusion site bruising - a phase IV clinical study of FDA data

Summary:

Infusion site bruising is found among people who take Nystatin, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Nystatin and have Infusion site bruising. It is created by eHealthMe based on reports of 28,671 people who have side effects when taking Nystatin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 24, 2023

28,671 people reported to have side effects when taking Nystatin.
Among them, 11 people (0.04%) have Infusion site bruising.


What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 29,024 Nystatin users for its effectiveness, alternative drugs and more.

What is Infusion site bruising?

Infusion site bruising is found to be associated with 452 drugs and 164 conditions by eHealthMe.

Number of Nystatin and Infusion site bruising reports submitted per year:

Could Nystatin cause Infusion site bruising?

Gender of people who have Infusion site bruising when taking Nystatin *:

  • female: 90.91 %
  • male: 9.09 %

Age of people who have Infusion site bruising when taking Nystatin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 40 %
  • 60+: 60 %

Common drugs people take besides Nystatin *:

  1. Linzess: 5 people, 45.45%
  2. Breo Ellipta: 4 people, 36.36%
  3. Hizentra: 4 people, 36.36%
  4. Pantoprazole: 4 people, 36.36%
  5. Vitamin B12: 4 people, 36.36%
  6. Zyrtec: 3 people, 27.27%
  7. Valacyclovir: 3 people, 27.27%
  8. Promethazine: 3 people, 27.27%
  9. Maxalt: 3 people, 27.27%
  10. Triamcinolone: 3 people, 27.27%

Common side effects people have besides Infusion site bruising *:

  1. Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 4 people, 36.36%
  2. Fatigue (feeling of tiredness): 4 people, 36.36%
  3. Infusion Site Swelling: 4 people, 36.36%
  4. Dizziness: 3 people, 27.27%
  5. Infusion Site Haemorrhage (bleeding from infusion site): 3 people, 27.27%
  6. Abdominal Pain Upper: 3 people, 27.27%
  7. Asthma: 3 people, 27.27%
  8. Abdominal Discomfort: 2 people, 18.18%
  9. Infusion Related Reaction: 2 people, 18.18%
  10. Infusion Site Erythema (reddening of the skin at infusion site): 2 people, 18.18%

Common conditions people have *:

  1. Immunodeficiency Common Variable: 11 people, 100.00%
  2. Primary Immunodeficiency Syndrome: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and have Infusion site bruising?

Check whether Infusion site bruising is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Infusion site bruising and when was it recovered:

Expand to all the drugs that have ingredients of nystatin:

Alternative drugs to, pros and cons of Nystatin:

Common Nystatin side effects:

Browse all side effects of Nystatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Infusion site bruising treatments and more:

COVID vaccines that are related to Infusion site bruising:

Common drugs associated with Infusion site bruising:

All the drugs that are associated with Infusion site bruising:

Common conditions associated with Infusion site bruising:

All the conditions that are associated with Infusion site bruising:

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystatin) and Nystatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: